Lacticaseibacillus rhamnosus R0011 and Reduced Gastrointestinal Symptom Rating Scale Score

• Efficacy and safety of Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 as an adjuvant for Helicobacter pylori eradication: a double-blind, randomized, placebo-controlled study.

  • 2023-09-14
  • RCT · n = 160
  • Frontiers in gastroenterology (Lausanne, Switzerland) 2
  • • Anya Kiattiweerasak
    • Natsuda Aumpan
    • Soonthorn Chonprasertsuk
    • Bubpha Pornthisarn
    • Sith Siramolpiwat
    • Patommatat Bhanthumkomol
    • Pongjarat Nunanan
    • Navapan Issariyakulkarn
    • Varocha Mahachai
    • Yoshio Yamaoka
    • Ratha-Korn Vilaichone

  • PubMed: 41821821
  • DOI: 10.3389/fgstr.2023.1245993

  5 Insights on

  • Reduced Gastrointestinal Symptom Rating Scale Score

  • High evidence

  the probiotic group had lower gastrointestinal symptom rating scale (GSRS) scores (1.46 ± 0.36 vs. 2.65 ± 0.66, p<0.001)

  Effect

  Beneficial

  Effect size

  Large

  Significant

  Yes